What ||| S:0 E:4 ||| WP
's  ||| S:4 E:7 ||| VBZ
new  ||| S:7 E:11 ||| JJ
in  ||| S:11 E:14 ||| IN
dermatological  ||| S:14 E:29 ||| JJ
research ||| S:29 E:37 ||| NN
?  ||| S:37 E:39 ||| .
Dermatological  ||| S:39 E:54 ||| JJ
research  ||| S:54 E:63 ||| NN
has  ||| S:63 E:67 ||| VBZ
been  ||| S:67 E:72 ||| VBN
very  ||| S:72 E:77 ||| RB
active  ||| S:77 E:84 ||| JJ
this  ||| S:84 E:89 ||| DT
year ||| S:89 E:93 ||| NN
.  ||| S:93 E:95 ||| .
Most  ||| S:95 E:100 ||| JJS
of  ||| S:100 E:103 ||| IN
the  ||| S:103 E:107 ||| DT
numerous  ||| S:107 E:116 ||| JJ
fields  ||| S:116 E:123 ||| NNS
investigated  ||| S:123 E:136 ||| VBD
involve  ||| S:136 E:144 ||| VB
the  ||| S:144 E:148 ||| DT
mechanisms  ||| S:148 E:159 ||| NNS
of  ||| S:159 E:162 ||| IN
cutaneous  ||| S:162 E:172 ||| JJ
regeneration  ||| S:172 E:185 ||| NN
and  ||| S:185 E:189 ||| CC
barrier  ||| S:189 E:197 ||| NN
function ||| S:197 E:205 ||| NN
.  ||| S:205 E:207 ||| .
A  ||| S:207 E:209 ||| DT
novel  ||| S:209 E:215 ||| NN
target  ||| S:215 E:222 ||| NN
of  ||| S:222 E:225 ||| IN
early  ||| S:225 E:231 ||| JJ
ultraviolet-induced  ||| S:231 E:251 ||| JJ
skin  ||| S:251 E:256 ||| NN
photodamage ||| S:256 E:267 ||| NN
,  ||| S:267 E:269 ||| ,
the  ||| S:269 E:273 ||| DT
Syk  ||| S:273 E:277 ||| JJ
kinase ||| S:277 E:283 ||| NN
,  ||| S:283 E:285 ||| ,
has  ||| S:285 E:289 ||| VBZ
been  ||| S:289 E:294 ||| VBN
recently  ||| S:294 E:303 ||| RB
identified ||| S:303 E:313 ||| VBN
.  ||| S:313 E:315 ||| .
Synergistic  ||| S:315 E:327 ||| JJ
relationship  ||| S:327 E:340 ||| NN
between  ||| S:340 E:348 ||| IN
telomere  ||| S:348 E:357 ||| JJ
damage  ||| S:357 E:364 ||| NN
and  ||| S:364 E:368 ||| CC
cutaneous  ||| S:368 E:378 ||| JJ
progerin  ||| S:378 E:387 ||| JJ
production  ||| S:387 E:398 ||| NN
during  ||| S:398 E:405 ||| IN
cell  ||| S:405 E:410 ||| NN
senescence  ||| S:410 E:421 ||| NNS
may  ||| S:421 E:425 ||| MD
also  ||| S:425 E:430 ||| RB
participate  ||| S:430 E:442 ||| VB
in  ||| S:442 E:445 ||| IN
the  ||| S:445 E:449 ||| DT
natural  ||| S:449 E:457 ||| JJ
skin  ||| S:457 E:462 ||| NN
aging  ||| S:462 E:468 ||| VBG
process ||| S:468 E:475 ||| NN
.  ||| S:475 E:477 ||| .
Interestingly ||| S:477 E:490 ||| RB
,  ||| S:490 E:492 ||| ,
ultraviolet  ||| S:492 E:504 ||| JJ
radiation  ||| S:504 E:514 ||| NN
induces  ||| S:514 E:522 ||| VBZ
an  ||| S:522 E:525 ||| DT
inhibitory  ||| S:525 E:536 ||| JJ
effect  ||| S:536 E:543 ||| NN
on  ||| S:543 E:546 ||| IN
subcutaneous  ||| S:546 E:559 ||| JJ
lipogenesis ||| S:559 E:570 ||| NN
.  ||| S:570 E:572 ||| .
Androgenetic  ||| S:572 E:585 ||| JJ
alopecia  ||| S:585 E:594 ||| NN
or  ||| S:594 E:597 ||| CC
common  ||| S:597 E:604 ||| JJ
baldness  ||| S:604 E:613 ||| NN
is  ||| S:613 E:616 ||| VBZ
not  ||| S:616 E:620 ||| RB
characterized  ||| S:620 E:634 ||| VBN
by  ||| S:634 E:637 ||| IN
loss  ||| S:637 E:642 ||| NN
of  ||| S:642 E:645 ||| IN
hair  ||| S:645 E:650 ||| NN
follicle  ||| S:650 E:659 ||| NNS
stem  ||| S:659 E:664 ||| VBP
cells  ||| S:664 E:670 ||| NNS
but  ||| S:670 E:674 ||| CC
by  ||| S:674 E:677 ||| IN
a  ||| S:677 E:679 ||| DT
defect  ||| S:679 E:686 ||| NN
in  ||| S:686 E:689 ||| IN
the  ||| S:689 E:693 ||| DT
conversion  ||| S:693 E:704 ||| NN
of  ||| S:704 E:707 ||| IN
hair  ||| S:707 E:712 ||| NN
follicle  ||| S:712 E:721 ||| NNS
stem  ||| S:721 E:726 ||| VBP
cells  ||| S:726 E:732 ||| NNS
into  ||| S:732 E:737 ||| IN
active  ||| S:737 E:744 ||| JJ
progenitor  ||| S:744 E:755 ||| JJ
cells ||| S:755 E:760 ||| NNS
.  ||| S:760 E:762 ||| .
It  ||| S:762 E:765 ||| PRP
has  ||| S:765 E:769 ||| VBZ
been  ||| S:769 E:774 ||| VBN
shown  ||| S:774 E:780 ||| VBN
that  ||| S:780 E:785 ||| IN
the  ||| S:785 E:789 ||| DT
cornified  ||| S:789 E:799 ||| JJ
envelope  ||| S:799 E:808 ||| NN
functions  ||| S:808 E:818 ||| NNS
not  ||| S:818 E:822 ||| RB
only  ||| S:822 E:827 ||| RB
as  ||| S:827 E:830 ||| IN
a  ||| S:830 E:832 ||| DT
physicomechanical  ||| S:832 E:850 ||| JJ
barrier ||| S:850 E:857 ||| NN
,  ||| S:857 E:859 ||| ,
but  ||| S:859 E:863 ||| CC
also  ||| S:863 E:868 ||| RB
as  ||| S:868 E:871 ||| IN
both  ||| S:871 E:876 ||| PDT
a  ||| S:876 E:878 ||| DT
biochemical  ||| S:878 E:890 ||| JJ
line  ||| S:890 E:895 ||| NN
of  ||| S:895 E:898 ||| IN
antoxidant  ||| S:898 E:909 ||| JJ
defense  ||| S:909 E:917 ||| NN
and  ||| S:917 E:921 ||| CC
an  ||| S:921 E:924 ||| DT
immunological  ||| S:924 E:938 ||| JJ
line  ||| S:938 E:943 ||| NN
of  ||| S:943 E:946 ||| IN
defense ||| S:946 E:953 ||| NN
.  ||| S:953 E:955 ||| .
Like  ||| S:955 E:960 ||| IN
human  ||| S:960 E:966 ||| JJ
papillomaviruses ||| S:966 E:982 ||| NN
,  ||| S:982 E:984 ||| ,
Merckel  ||| S:984 E:992 ||| NNP
cell  ||| S:992 E:997 ||| NN
polyomavirus  ||| S:997 E:1010 ||| NN
belongs  ||| S:1010 E:1018 ||| VBZ
to  ||| S:1018 E:1021 ||| TO
the  ||| S:1021 E:1025 ||| DT
skin  ||| S:1025 E:1030 ||| NN
microbiome  ||| S:1030 E:1041 ||| NNS
and  ||| S:1041 E:1045 ||| CC
different  ||| S:1045 E:1055 ||| JJ
studies  ||| S:1055 E:1063 ||| NNS
have  ||| S:1063 E:1068 ||| VBP
demonstrated  ||| S:1068 E:1081 ||| VBN
the  ||| S:1081 E:1085 ||| DT
protective  ||| S:1085 E:1096 ||| JJ
role  ||| S:1096 E:1101 ||| NN
of  ||| S:1101 E:1104 ||| IN
epidermal  ||| S:1104 E:1114 ||| JJ
resident  ||| S:1114 E:1123 ||| NN
microflora  ||| S:1123 E:1134 ||| NN
through  ||| S:1134 E:1142 ||| IN
the  ||| S:1142 E:1146 ||| DT
activation  ||| S:1146 E:1157 ||| NN
of  ||| S:1157 E:1160 ||| IN
innate  ||| S:1160 E:1167 ||| JJ
immunity ||| S:1167 E:1175 ||| NN
.  ||| S:1175 E:1177 ||| .
Production  ||| S:1177 E:1188 ||| NN
of  ||| S:1188 E:1191 ||| IN
antimicrobial  ||| S:1191 E:1205 ||| JJ
peptides  ||| S:1205 E:1214 ||| NN
and  ||| S:1214 E:1218 ||| CC
the  ||| S:1218 E:1222 ||| DT
activation  ||| S:1222 E:1233 ||| NN
of  ||| S:1233 E:1236 ||| IN
inflammasome  ||| S:1236 E:1249 ||| NN
and  ||| S:1249 E:1253 ||| CC
plasmacytoid  ||| S:1253 E:1266 ||| JJ
dendritic  ||| S:1266 E:1276 ||| JJ
cells  ||| S:1276 E:1282 ||| NNS
are  ||| S:1282 E:1286 ||| VBP
involved  ||| S:1286 E:1295 ||| VBN
in  ||| S:1295 E:1298 ||| IN
the  ||| S:1298 E:1302 ||| DT
modulation  ||| S:1302 E:1313 ||| NN
of  ||| S:1313 E:1316 ||| IN
the  ||| S:1316 E:1320 ||| DT
cutaneous  ||| S:1320 E:1330 ||| JJ
barrier  ||| S:1330 E:1338 ||| NN
function ||| S:1338 E:1346 ||| NN
.  ||| S:1346 E:1348 ||| .
Results  ||| S:1348 E:1356 ||| NNS
from  ||| S:1356 E:1361 ||| IN
different  ||| S:1361 E:1371 ||| JJ
studies  ||| S:1371 E:1379 ||| NNS
suggest  ||| S:1379 E:1387 ||| VBP
that  ||| S:1387 E:1392 ||| IN
IL-22  ||| S:1392 E:1398 ||| NNP
and  ||| S:1398 E:1402 ||| CC
IL-36  ||| S:1402 E:1408 ||| NNP
may  ||| S:1408 E:1412 ||| MD
be  ||| S:1412 E:1415 ||| VB
common  ||| S:1415 E:1422 ||| JJ
mediators  ||| S:1422 E:1432 ||| NNS
of  ||| S:1432 E:1435 ||| IN
both  ||| S:1435 E:1440 ||| DT
innate  ||| S:1440 E:1447 ||| NN
and  ||| S:1447 E:1451 ||| CC
adaptive  ||| S:1451 E:1460 ||| JJ
immune  ||| S:1460 E:1467 ||| JJ
responses ||| S:1467 E:1476 ||| NNS
.  ||| S:1476 E:1478 ||| .
All  ||| S:1478 E:1482 ||| PDT
these  ||| S:1482 E:1488 ||| DT
pathways  ||| S:1488 E:1497 ||| JJ
interact  ||| S:1497 E:1506 ||| NNS
not  ||| S:1506 E:1510 ||| RB
only  ||| S:1510 E:1515 ||| RB
to  ||| S:1515 E:1518 ||| TO
maintain  ||| S:1518 E:1527 ||| VB
cutaneous  ||| S:1527 E:1537 ||| JJ
homeostasis  ||| S:1537 E:1549 ||| NN
and  ||| S:1549 E:1553 ||| CC
integrity  ||| S:1553 E:1563 ||| NN
( ||| S:1563 E:1564 ||| -LRB-
wound  ||| S:1564 E:1570 ||| FW
healing ||| S:1570 E:1577 ||| FW
)  ||| S:1577 E:1579 ||| -RRB-
but  ||| S:1579 E:1583 ||| CC
also  ||| S:1583 E:1588 ||| RB
to  ||| S:1588 E:1591 ||| TO
regulate  ||| S:1591 E:1600 ||| VB
autoinflammatory  ||| S:1600 E:1617 ||| NNS
and  ||| S:1617 E:1621 ||| CC
autoimmune  ||| S:1621 E:1632 ||| JJ
dermatoses  ||| S:1632 E:1643 ||| NNS
( ||| S:1643 E:1644 ||| -LRB-
psoriasis ||| S:1644 E:1653 ||| UH
,  ||| S:1653 E:1655 ||| ,
lupus ||| S:1655 E:1660 ||| NN
,  ||| S:1660 E:1662 ||| ,
rosacea ||| S:1662 E:1669 ||| NN
,  ||| S:1669 E:1671 ||| ,
atopic  ||| S:1671 E:1678 ||| JJ
dermatitis ||| S:1678 E:1688 ||| NN
,  ||| S:1688 E:1690 ||| ,
etc... ||| S:1690 E:1696 ||| CD
) ||| S:1696 E:1697 ||| -RRB-
.  ||| S:1697 E:1699 ||| .
In  ||| S:1699 E:1702 ||| IN
addition ||| S:1702 E:1710 ||| NN
,  ||| S:1710 E:1712 ||| ,
molecular  ||| S:1712 E:1722 ||| JJ
mechanisms  ||| S:1722 E:1733 ||| NNS
that  ||| S:1733 E:1738 ||| IN
regulate  ||| S:1738 E:1747 ||| JJ
T  ||| S:1747 E:1749 ||| NN
helper  ||| S:1749 E:1756 ||| NN
type  ||| S:1756 E:1761 ||| NN
2  ||| S:1761 E:1763 ||| CD
differentiation  ||| S:1763 E:1779 ||| NNS
and  ||| S:1779 E:1783 ||| CC
the  ||| S:1783 E:1787 ||| DT
retention  ||| S:1787 E:1797 ||| NN
at  ||| S:1797 E:1800 ||| IN
the  ||| S:1800 E:1804 ||| DT
site  ||| S:1804 E:1809 ||| NN
of  ||| S:1809 E:1812 ||| IN
inflammation  ||| S:1812 E:1825 ||| NN
of  ||| S:1825 E:1828 ||| IN
Th2  ||| S:1828 E:1832 ||| CD
cells  ||| S:1832 E:1838 ||| NNS
have  ||| S:1838 E:1843 ||| VBP
been  ||| S:1843 E:1848 ||| VBN
identified ||| S:1848 E:1858 ||| VBN
.  ||| S:1858 E:1860 ||| .
New  ||| S:1860 E:1864 ||| JJ
promising  ||| S:1864 E:1874 ||| JJ
therapeutic  ||| S:1874 E:1886 ||| JJ
targets  ||| S:1886 E:1894 ||| NNS
for  ||| S:1894 E:1898 ||| IN
different  ||| S:1898 E:1908 ||| JJ
chronic  ||| S:1908 E:1916 ||| JJ
dermatosis  ||| S:1916 E:1927 ||| NNS
are  ||| S:1927 E:1931 ||| VBP
thus  ||| S:1931 E:1936 ||| RB
suggested ||| S:1936 E:1945 ||| VBD
.  ||| S:1945 E:1947 ||| .
Mechanobiology  ||| S:1947 E:1962 ||| NNP
and  ||| S:1962 E:1966 ||| CC
mechanotransduction  ||| S:1966 E:1986 ||| NNS
are  ||| S:1986 E:1990 ||| VBP
also  ||| S:1990 E:1995 ||| RB
emerging  ||| S:1995 E:2004 ||| VBG
fields  ||| S:2004 E:2011 ||| NNS
that  ||| S:2011 E:2016 ||| IN
investigate  ||| S:2016 E:2028 ||| JJ
mechanical  ||| S:2028 E:2039 ||| JJ
interactions  ||| S:2039 E:2052 ||| NNS
between  ||| S:2052 E:2060 ||| IN
living  ||| S:2060 E:2067 ||| VBG
cells  ||| S:2067 E:2073 ||| NNS
and  ||| S:2073 E:2077 ||| CC
their  ||| S:2077 E:2083 ||| PRP$
environment  ||| S:2083 E:2095 ||| NN
and  ||| S:2095 E:2099 ||| CC
the  ||| S:2099 E:2103 ||| DT
conversion  ||| S:2103 E:2114 ||| NN
of  ||| S:2114 E:2117 ||| IN
mechanical  ||| S:2117 E:2128 ||| JJ
cues  ||| S:2128 E:2133 ||| NNS
into  ||| S:2133 E:2138 ||| IN
biochemical  ||| S:2138 E:2150 ||| JJ
signals ||| S:2150 E:2157 ||| NNS
.  ||| S:2157 E:2159 ||| .
Electronic  ||| S:2159 E:2170 ||| JJ
second  ||| S:2170 E:2177 ||| JJ
skin  ||| S:2177 E:2182 ||| NN
is  ||| S:2182 E:2185 ||| VBZ
now  ||| S:2185 E:2189 ||| RB
a  ||| S:2189 E:2191 ||| DT
current  ||| S:2191 E:2199 ||| JJ
concept  ||| S:2199 E:2207 ||| NN
through  ||| S:2207 E:2215 ||| IN
bio-integrated  ||| S:2215 E:2230 ||| JJ
epidermal  ||| S:2230 E:2240 ||| JJ
electronics  ||| S:2240 E:2252 ||| NNS
platforms  ||| S:2252 E:2262 ||| VBP
used  ||| S:2262 E:2267 ||| VBN
for  ||| S:2267 E:2271 ||| IN
different  ||| S:2271 E:2281 ||| JJ
monitoring  ||| S:2281 E:2292 ||| NN
and  ||| S:2292 E:2296 ||| CC
stimulations  ||| S:2296 E:2309 ||| NN
of  ||| S:2309 E:2312 ||| IN
body  ||| S:2312 E:2317 ||| NN
functions ||| S:2317 E:2326 ||| NNS
.  ||| S:2326 E:2328 ||| .
